Edition:
United States

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

79.96USD
25 May 2018
Change (% chg)

$-0.62 (-0.77%)
Prev Close
$80.58
Open
$80.68
Day's High
$81.85
Day's Low
$79.19
Volume
704,022
Avg. Vol
1,111,509
52-wk High
$111.36
52-wk Low
$17.52

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 5.22 December 26 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 7 7 4 4
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.75 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 10 1,033.34 1,134.00 923.50 57.99
Quarter Ending Sep-18 10 53.36 136.00 21.10 46.48
Year Ending Dec-18 10 1,178.83 1,392.00 1,100.70 192.44
Year Ending Dec-19 9 264.33 605.00 95.40 246.59
Earnings (per share)
Quarter Ending Jun-18 10 5.22 5.89 4.32 -0.20
Quarter Ending Sep-18 10 -0.48 0.10 -0.72 -0.28
Year Ending Dec-18 10 3.64 5.12 3.09 -1.01
Year Ending Dec-19 9 -1.61 1.05 -3.38 -0.63

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 35.62 38.02 2.40 6.75
Quarter Ending Dec-17 36.98 95.47 58.49 158.18
Quarter Ending Sep-17 117.32 152.93 35.61 30.35
Quarter Ending Jun-17 34.23 34.59 0.36 1.05
Quarter Ending Mar-17 26.80 24.73 2.07 7.73

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1,033.34 1,033.34 248.28 301.61 57.99
Quarter Ending Sep-18 53.36 53.36 82.40 102.20 46.48
Year Ending Dec-18 1,178.83 1,178.83 540.14 526.87 192.44
Year Ending Dec-19 264.33 264.33 299.92 352.18 246.59

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 10 0
Quarter Ending Sep-18 0 0 3 5
Year Ending Dec-18 0 0 8 2
Year Ending Dec-19 0 0 3 4
Earnings